Publication | Open Access
Duration by Design: Discovery of Revefenacin, the First-in-Class Nebulized Once-Daily Bronchodilator for the Treatment of Patients With COPD
10
Citations
0
References
2016
Year
AsthmaPulmonary CareAdvanced Lung DiseasePulmonary PharmacologyPulmonary MedicineMedicinePulmonary Disease
No additional data available for this publication yet. Check back later!